In the latest trading session, 0.4 million Outset Medical Inc (NASDAQ:OM) shares changed hands as the company’s beta touched 1.98. With the company’s most recent per share price at $0.79 changed hands at -$0.03 or -3.66% at last look, the market valuation stands at $42.31M. OM’s current price is a discount, trading about -560.76% off its 52-week high of $5.22. The share price had its 52-week low at $0.44, which suggests the last value was 44.3% up since then.
Analysts gave the Outset Medical Inc (OM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.80. If we narrow down to specifics, the data shows that 0 out of 8 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended OM as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. Outset Medical Inc’s EPS for the current quarter is expected to be -0.26.
Outset Medical Inc (NASDAQ:OM) trade information
Instantly OM was in red as seen in intraday trades today. With action -16.19%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -29.02%, with the 5-day performance at -16.19% in the red. However, in the 30-day time frame, Outset Medical Inc (NASDAQ:OM) is -6.85% down.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 86.83% from its recent market value. According to analyst projections, OM’s forecast low is 3 with 34 as the target high. To hit the forecast high, the stock’s price needs a -4203.8% plunge from its current level, while the stock would need to soar -279.75% for it to hit the projected low.
Outset Medical Inc (OM) estimates and forecasts
Year-over-year growth is forecast to reach 5.78% up from the last financial year.
Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of 27.81M. 5 analysts are of the opinion that Outset Medical Inc’s revenue for the current quarter will be 29.14M. The company’s revenue for the corresponding quarters a year ago was 28.17M and 27.39M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -1.26%. The estimates for the next quarter sales put growth at 6.39%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -4.06%. The 2025 estimates are for Outset Medical Inc earnings to increase by 42.57%, but the outlook for the next 5-year period is at 29.58% per year.
Outset Medical Inc (NASDAQ:OM)’s Major holders
AMERIPRISE FINANCIAL INC holds the second largest percentage of outstanding shares, with 10.2162% or 5.2 million shares worth $20.02 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Select Portfolios – Medical Technology & Devices Port and Vanguard Total Stock Market Index Fund. With 3.3 shares estimated at $2.55 million under it, the former controlled 6.14% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 3.07% of the shares, roughly 1.65 shares worth around $1.27 million.
